Photodynamic Therapy of Actinic Keratoses With Alacare®

This study is currently recruiting participants.
Verified April 2012 by photonamic GmbH & Co. KG
Sponsor:
Information provided by (Responsible Party):
photonamic GmbH & Co. KG
ClinicalTrials.gov Identifier:
NCT01571336
First received: April 3, 2012
Last updated: April 26, 2012
Last verified: April 2012
  Purpose

This study aims to collect data on the frequency of SCCs in the Alacare®-treated area during an interval of two years after Alacare®-PDT.


Condition
Actinic Keratosis

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Non-interventional Observational Study on Photodynamic Therapy of Actinic Keratoses With Alacare®

Further study details as provided by photonamic GmbH & Co. KG:

Primary Outcome Measures:
  • Number of SCCs in areas treated with Alacare®-PDT [ Time Frame: Two years after Alacare®-PDT ] [ Designated as safety issue: Yes ]

Estimated Enrollment: 420
Study Start Date: April 2012
Estimated Study Completion Date: August 2015
Estimated Primary Completion Date: April 2015 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Community sample

Criteria

Inclusion Criteria:

  • Written informed consent
  • Patients with 3 to 6 mild AK lesions on the hairless areas of the head and face which were treated with Alacare®-PDT according to the SPC
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01571336

Contacts
Contact: Andrea Ebeling, PhD a.ebeling@photonamic.de
Contact: Marcus Stocker, PhD m.stocker@photonamic.de

Locations
Germany
Medizinisches Zentrum Bonn Friedensplatz Recruiting
Bonn, Germany, 53111
Principal Investigator: Uwe Reinhold, Prof. Dr.            
Hautärztliche Gemeinschaftspraxis Dr. med. Peter Dworzak Dr. med. Peter Radny Recruiting
Friedrichshafen, Germany, 88045
Principal Investigator: Peter Radny, MD            
Gemeinschaftspraxis Dres.Ina Röhrig-Petering und Holger Petering Recruiting
Hildesheim, Germany, 31134
Principal Investigator: Holger Petering, PD Dr.            
Dermatologische Gemeinschaftspraxis Prof. Dr. J. Gille & Dr. K. Spieth-Gille Recruiting
Königstein im Taunus, Germany, 61462
Principal Investigator: Jens Gille, Prof. Dr.            
ZENTderma Recruiting
Mönchengladbach, Germany, 41061
Principal Investigator: Rolf Ostendorf, MD            
Facharzt für Haut- und Geschlechtskrankheiten Recruiting
Radolfzell, Germany, 78315
Principal Investigator: Andras Rozsondai, MD            
Praxis Prof. Dr. Thomas Dirschka Recruiting
Wuppertal, Germany, 42275
Principal Investigator: Thomas Dirschka, Prof. Dr.            
Sponsors and Collaborators
photonamic GmbH & Co. KG
Investigators
Study Chair: Peter Radny, MD Dermatological group practice, Charlottenstraße 12, D-88045 Friedrichshafen, Germany
  More Information

No publications provided

Responsible Party: photonamic GmbH & Co. KG
ClinicalTrials.gov Identifier: NCT01571336     History of Changes
Other Study ID Numbers: NIS 01
Study First Received: April 3, 2012
Last Updated: April 26, 2012
Health Authority: Germany: Federal Institute for Drugs and Medical Devices

Additional relevant MeSH terms:
Keratosis
Keratosis, Actinic
Skin Diseases
Precancerous Conditions
Neoplasms

ClinicalTrials.gov processed this record on May 23, 2013